320 related articles for article (PubMed ID: 27264036)
1. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.
Riva N; Ageno W; Schulman S; Beyer-Westendorf J; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Dentali F;
Lancet Haematol; 2016 Jun; 3(6):e267-75. PubMed ID: 27264036
[TBL] [Abstract][Full Text] [Related]
2. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
[TBL] [Abstract][Full Text] [Related]
3. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
[TBL] [Abstract][Full Text] [Related]
4. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.
Søgaard KK; Adelborg K; Darvalics B; Horváth-Puhó E; Beyer-Westendorf J; Ageno W; Sørensen HT
Lancet Haematol; 2018 Oct; 5(10):e441-e449. PubMed ID: 30201587
[TBL] [Abstract][Full Text] [Related]
5. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.
Condat B; Pessione F; Hillaire S; Denninger MH; Guillin MC; Poliquin M; Hadengue A; Erlinger S; Valla D
Gastroenterology; 2001 Feb; 120(2):490-7. PubMed ID: 11159889
[TBL] [Abstract][Full Text] [Related]
6. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
Senzolo M; Riva N; Dentali F; Rodriguez-Castro K; Sartori MT; Bang SM; Martinelli I; Schulman S; Alatri A; Beyer-Westendorf J; Di Minno MND; Ageno W;
Clin Transl Gastroenterol; 2018 Aug; 9(8):176. PubMed ID: 30108204
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry.
Ageno W; Riva N; Schulman S; Bang SM; Sartori MT; Grandone E; Beyer-Westendorf J; Barillari G; Di Minno MN; Dentali F;
Semin Thromb Hemost; 2014 Feb; 40(1):99-105. PubMed ID: 24381147
[TBL] [Abstract][Full Text] [Related]
11. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.
Violi F; Corazza GR; Caldwell SH; Perticone F; Gatta A; Angelico M; Farcomeni A; Masotti M; Napoleone L; Vestri A; Raparelli V; Basili S;
Intern Emerg Med; 2016 Dec; 11(8):1059-1066. PubMed ID: 27026379
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
[TBL] [Abstract][Full Text] [Related]
13. Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital.
Jørgensen CT; Tavoly M; Førsund E; Pettersen HH; Tjønnfjord E; Ghanima W; Brækkan SK
J Thromb Haemost; 2023 Oct; 21(10):2824-2832. PubMed ID: 37394122
[TBL] [Abstract][Full Text] [Related]
14. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis.
Candeloro M; Valeriani E; Monreal M; Ageno W; Riva N; Schulman S; Bang SM; Mellado M; Díaz-Peromingo JA; Moisés J; Díaz-Brasero AM; Garcia-Pagan JC; Perez-Campuzano V; Senzolo M; De Gottardi A; Di Nisio M
J Thromb Haemost; 2023 Jun; 21(6):1592-1600. PubMed ID: 36907381
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.
Mier-Hicks A; Raj M; Do RK; Yu KH; Lowery MA; Varghese A; O'Reilly EM
Clin Colorectal Cancer; 2018 Jun; 17(2):121-128. PubMed ID: 29477452
[TBL] [Abstract][Full Text] [Related]
16. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis.
Baiges A; Procopet B; Silva-Junior G; Llop E; Tellez L; Darnell A; Garcia-Criado Á; Turon F; Nicoara-Farcau O; González-Alayón C; Larrue H; Magaz M; Olivas P; Perez-Campuzano V; Calleja JL; Albillos A; Reverter JC; Bureau C; Bosch J; Hernández-Gea V; Garcia-Pagán JC; ; ;
J Hepatol; 2023 Jan; 78(1):114-122. PubMed ID: 36058365
[TBL] [Abstract][Full Text] [Related]
17. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
[TBL] [Abstract][Full Text] [Related]
18. Survival and recurrence in patients with splanchnic vein thromboses.
Thatipelli MR; McBane RD; Hodge DO; Wysokinski WE
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):200-5. PubMed ID: 19782767
[TBL] [Abstract][Full Text] [Related]
19. Initial management of noncirrhotic splanchnic vein thrombosis: when is anticoagulation enough?
Ravichandran P; Croome KP; Kovacs MJ; Lazo-Langner A; Hernandez-Alejandro R
Can J Gastroenterol Hepatol; 2014 Apr; 28(4):207-11. PubMed ID: 24729995
[TBL] [Abstract][Full Text] [Related]
20. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
